Embla Medical hf. (CPH:EMBLA)

Market Cap	11.14B -4.7%
Revenue (ttm)	6.21B +11.7%
Net Income	555.09M +18.6%
EPS	1.31 +19.1%
Shares Out	426.70M
PE Ratio	19.97
Forward PE	18.00
Dividend	n/a
Ex-Dividend Date	n/a

Volume	62,578
Average Volume	148,476
Open	26.10
Previous Close	26.10
Day's Range	26.00 - 26.35
52-Week Range	25.00 - 37.90
Beta	0.45
RSI	36.61
Earnings Date	Apr 28, 2026

About Embla Medical

Embla Medical hf., together with its subsidiaries, provides non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It operates through three segments: Prosthetics and Neuro Orthotics, Bracing and Supports, and Patient Care. The Prosthetics and Neuro Orthotics segment offers mechanical products, such as lower and upper limb loss or difference; and bionic products microprocessor-controlled feet, knees, hands, fingers, and neuro orthotic joints. Its Bracing and Supports segment provides bracing and...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1971
• Employees: 4,500
• Stock Exchange: Copenhagen Stock Exchange
• Ticker Symbol: EMBLA

Financial Performance

In 2025, Embla Medical's revenue was $928.69 million, an increase of 8.63% compared to the previous year's $854.89 million. Earnings were $83.34 million, an increase of 22.05%.

Financial numbers in USD